Biological Products, (No Diagnostic Substances)·OXFORDSHIRE, X0
Summary Financials
Revenue
$249.4M
+43.1% YoY
FY 2025
Adj. EBITDA
-$55.5M
-22.3% margin
FY 2025
Net Income
-$55.3M
-22.2% margin
FY 2025
EPS (Diluted)
-$1.13
FY 2025
Stock Price
$30.86
-0.6%
2026-03-13
52W Range
$23.15 – $40.71
P/E Ratio
-27.3x
Market Cap
$1.6B
Cash
$455.7M
FY 2025
Total Debt
—
Net Cash
$455.7M
FY 2025
Enterprise Value
$1.1B
Debt / EBITDA
8.2x
FY 2025
EV / EBITDA
-20.0x
Employees
—
Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.